Curebay Technologies Private Limited - Due diligence report

A 360° intelligence report on Curebay: trust score, financial health, credit view, compliance, directors, growth and distress signals - gene…

2020-12-25 Bhubaneswar, Orissa Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Curebay — 360° Intelligence Report

Generated from MCA filings & public records
74/100
Trust Score
Moderate

Curebay is assessed as Moderate with a Trust Score of 74/100. Curebay is an active private limited indian non-government company incorporated in 2020, operating in the Internet sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 30 Oct 2026 from the latest processed filings. Curebay Technologies Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
74/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
73/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Working-capital cover adequate.

Charges position: 3 open (20.70 cr) · 1 satisfied (7.50 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others3 48.0 cr
Hdfc Bank Limited1 48.0 cr
Compliance Score: 73/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Litigation present in 1 court forum(s).
  • Delayed payments to MSME suppliers disclosed (2 disclosure(s)).
  • 2 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
BHASKAR PRAMANIK 01234567 Director 01/04/2018 6 yrs Approved
PRIYADARSHI MOHAPATRA 01234567 Director 01/04/2018 6 yrs Approved
JYOTSNA KRISHNAN 01234567 Director 01/04/2018 6 yrs Approved
SANJAY KUMAR SWAIN 01234567 Director 01/04/2018 6 yrs Approved
Swati Murarka 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
3
Group entities
3
Capital events
8 allotment(s) · 3 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Curebay Clinics Private Limited Subsidiary Company 74.00%
Curebay Pharmacy Private Limited Subsidiary Company 74.00%
Helixotech Private Limited Subsidiary Company 74.00%

Key managerial personnel: PRIYADARSHI MOHAPATRA (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 75
Growth signals & trust indicators
Latest year revenue grew 38%.
Asset base grew 1.42 - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 5 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
3 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 56,758.00.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence74/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment56/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 20.70 cr already registered.
  • Compliance record supports lending.
Investor view68/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
26 Sep 2025
Last AGM held
Annual general meeting
20 Aug 2025
Charge created
Others - 10.00 cr
12 Aug 2025
Charge created
Others - 10.00 cr
10 Jul 2025
Charge satisfied
Others
08 Jul 2025
Director appointed
Swati Murarka (Nominee Director)
01 Jul 2025
Director appointed
BHASKAR PRAMANIK (Director)
26 Jun 2025
Charge created
Hdfc Bank Limited - 70.23 Lakh
11 Jun 2025
Director appointed
SANJAY KUMAR SWAIN (Director)
03 Jun 2025
Director ceased
SHOBHAN MAHAPATRA
31 Mar 2025
Latest balance sheet
Filed with ROC
29 Sep 2023
Director ceased
BHASKAR PRAMANIK
Director ceased
RANDY CHARLES BELCHER
21 Aug 2023
Charge created
Others - 7.50 cr
31 Mar 2023
Share transfer (FY 2023)
75188.00000000 shares to Hemani Intermediates Private Limite
28 Feb 2023
Director appointed
JYOTSNA KRISHNAN (Nominee Director)
10

Key Observations

Auto-generated from the data above
Net worth is positive.
5 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 3 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 8 security allotment(s) - amounts available in the full report.
1 overseas direct investment(s) (ODI) on record - international footprint.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Labassure U73100MH2011PTC217004 Mumbai, Maharashtra, India
Bis Bhoomi India Private Limited U93000RJ2020PTC072619 Jaipur, Rajasthan, India
Dr Spine Care Private Limited U85190KA2021PTC153704 Bengaluru, Karnataka, India
Medimaa Diagnostics Private Limited U85100DL2019PTC348381 New Delhi, Delhi, India
Udichi Ent & Head-Neck Centre Private Limited U85110WB2004PTC098714 Kolkata, West Bengal, India
Acpc Healthcare Private Limited U74994MH2018PTC314054 Malad West, Maharashtra, India
Iindoworld Mediserve U85100MH2018PTC315456 Dist Latur Latur, Maharashtra, India
Globaux Impex Private Limited U74999GJ2016PTC094638 Vadodara, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Curebay before audits and certifications: compliance score 73/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Curebay: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Curebay - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 74/100, distress signals and MSME payment-delay disclosures - know whether Curebay pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Curebay - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Curebay an active company?

Curebay has MCA status “Active” with a compliance score of 73/100 (Moderate).

Is Curebay financially healthy?

Curebay has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Curebay?

Its overall Trust Score is 74/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Curebay?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Curebay have loans or charges against its assets?

3 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Curebay up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 73/100 (Moderate).

Is it risky to lend to Curebay?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.